Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of ac… Read more
Sandoz Group AG (SDZXF) - Total Assets
Latest total assets as of December 2025: $22.03 Billion USD
Based on the latest financial reports, Sandoz Group AG (SDZXF) holds total assets worth $22.03 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sandoz Group AG - Total Assets Trend (2022–2025)
This chart illustrates how Sandoz Group AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sandoz Group AG - Asset Composition Analysis
Current Asset Composition (December 2025)
Sandoz Group AG's total assets of $22.03 Billion consist of 37.1% current assets and 62.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.9% |
| Accounts Receivable | $2.51 Billion | 11.4% |
| Inventory | $2.85 Billion | 12.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.87 Billion | 8.5% |
| Goodwill | $8.01 Billion | 36.4% |
Asset Composition Trend (2022–2025)
This chart illustrates how Sandoz Group AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sandoz Group AG's current assets represent 37.1% of total assets in 2025, a decrease from 5976000.0% in 2022.
- Cash Position: Cash and equivalents constituted 7.9% of total assets in 2025, down from 100.0% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, a decrease from 8891000.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 36.4% of total assets.
Sandoz Group AG Competitors by Total Assets
Key competitors of Sandoz Group AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM
|
USA | $41.43 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
USA | $10.70K |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Sandoz Group AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Sandoz Group AG generates 0.51x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Sandoz Group AG generates $ 4.15 in net profit.
Sandoz Group AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.18 | 1.24 | 0.79 |
| Quick Ratio | 0.77 | 0.79 | 0.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.27 Billion | $ 1.49 Billion | $ -1.94 Billion |
Sandoz Group AG - Advanced Valuation Insights
This section examines the relationship between Sandoz Group AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.68 |
| Latest Market Cap to Assets Ratio | 0.78 |
| Asset Growth Rate (YoY) | 10.7% |
| Total Assets | $22.03 Billion |
| Market Capitalization | $17.13 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Sandoz Group AG's assets below their book value (0.78 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Sandoz Group AG's assets grew by 10.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Sandoz Group AG (2022–2025)
The table below shows the annual total assets of Sandoz Group AG from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $22.03 Billion | +10.67% |
| 2024-12-31 | $19.91 Billion | +2.45% |
| 2023-12-31 | $19.43 Billion | +19429900.00% |
| 2022-12-31 | $100.00K | -- |